Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Longitudinal change of COPD assessment test (CAT) in a telehealthcare cohort is associated with exacerbation risk.

Rassouli F, Baty F, Stolz D, Albrich WC, Tamm M, Widmer S, Brutsche MH.

Int J Chron Obstruct Pulmon Dis. 2017 Oct 24;12:3103-3109. doi: 10.2147/COPD.S141646. eCollection 2017.

2.

Multimodel inference applied to oxygen recovery kinetics after 6-min walk tests in patients with chronic obstructive pulmonary disease.

Baty F, Ritz C, Jensen SM, Kern L, Tamm M, Brutsche MH.

PLoS One. 2017 Nov 8;12(11):e0187548. doi: 10.1371/journal.pone.0187548. eCollection 2017.

3.

Session 59. Biosignal processing and monitoring IV.

Annaheim S, Camenzind M, Schoch O, Brutsche M, Baty F, Rossi R.

Biomed Tech (Berl). 2017 Aug 28;62(s1):s526-s530. doi: 10.1515/bmt-2017-5101. No abstract available.

PMID:
28865190
4.

Comparing social group identifications and socioeconomic deprivation as predictors of psychological distress: Evidence from a Scottish primary care sample.

Cientanni F, Power K, Sani F, Wright C, Baty F, Hustings K, Morgan D, Tanner G.

Br J Soc Psychol. 2017 Dec;56(4):705-722. doi: 10.1111/bjso.12210. Epub 2017 Jul 25.

PMID:
28741679
5.

24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling.

Baty F, Joerger M, Früh M, Klingbiel D, Zappa F, Brutsche M.

J Transl Med. 2017 Mar 30;15(1):66. doi: 10.1186/s12967-017-1174-z.

6.

Prognostic and predictive value of loss of nuclear RAD51 immunoreactivity in resected non-small cell lung cancer patients.

Gachechiladze M, Škarda J, Kolek V, Grygárková I, Langová K, Bouchal J, Kolář Z, Baty F, Stahel R, Weder W, Soltermann A, Joerger M.

Lung Cancer. 2017 Mar;105:31-38. doi: 10.1016/j.lungcan.2017.01.009. Epub 2017 Jan 18.

PMID:
28236982
7.

Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.

Feigelman R, Kahlert CR, Baty F, Rassouli F, Kleiner RL, Kohler P, Brutsche MH, von Mering C.

Microbiome. 2017 Feb 10;5(1):20. doi: 10.1186/s40168-017-0234-1.

8.

Transcutaneous versus blood carbon dioxide monitoring during acute noninvasive ventilation in the emergency department - a retrospective analysis.

Horvath CM, Brutsche MH, Baty F, Rüdiger JJ.

Swiss Med Wkly. 2016 Oct 26;146:w14373. doi: 10.4414/smw.2016.14373. eCollection 2016.

9.

SUVmax and Tumour Location in PET-CT Predict Oncogene Status in Lung Cancer.

Putora PM, Szentesi K, Glatzer M, Rodriguez R, Müller J, Baty F, Früh M.

Oncol Res Treat. 2016;39(11):681-686. Epub 2016 Oct 19.

10.

Oxygen Uptake Recovery Kinetics after the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease.

Baty F, van Gestel AJ, Kern L, Brutsche MH.

Respiration. 2016;92(6):371-379. Epub 2016 Nov 9.

PMID:
27825150
11.

Erratum to: NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours.

Horvath CM, Brutsche MH, Schoch OD, Schillig B, Baty F, vonOw D, Rüdiger JJ.

Intern Emerg Med. 2017 Dec;12(8):1339. doi: 10.1007/s11739-016-1569-5. No abstract available.

PMID:
27804075
12.

NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours.

Horvath CM, Brutsche MH, Schoch OD, Schillig B, Baty F, vonOw D, Rüdiger JJ.

Intern Emerg Med. 2017 Dec;12(8):1215-1223. doi: 10.1007/s11739-016-1546-z. Epub 2016 Oct 8. Erratum in: Intern Emerg Med. 2017 Dec;12 (8):1339. Brutsche, Martin Horvath [corrected to Brutsche, Martin Hugo].

PMID:
27722910
13.

Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study.

Neumair P, Joos L, Warschkow R, Dutly A, Ess S, Hitz F, Früh M, Brutsche M, Baty F, Krähenbühl S, Cerny T, Joerger M.

Lung Cancer. 2016 Oct;100:38-44. doi: 10.1016/j.lungcan.2016.07.027. Epub 2016 Jul 28.

PMID:
27597279
14.

Telehealthcare for Chronic Obstructive Pulmonary Disease in Switzerland Is Feasible and Appreciated by Patients.

Rassouli F, Pfister M, Widmer S, Baty F, Burger B, Brutsche MH.

Respiration. 2016;92(2):107-13. doi: 10.1159/000448377. Epub 2016 Aug 24.

15.

Modeling the oxygen uptake kinetics during exercise testing of patients with chronic obstructive pulmonary diseases using nonlinear mixed models.

Baty F, Ritz C, van Gestel A, Brutsche M, Gerhard D.

BMC Med Res Methodol. 2016 Jun 1;16:66. doi: 10.1186/s12874-016-0173-8.

16.

Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment.

Cernomaz AT, Macovei II, Pavel I, Grigoriu C, Marinca M, Baty F, Peter S, Zonda R, Brutsche M, Grigoriu B.

BMC Pulm Med. 2016 May 23;16(1):88. doi: 10.1186/s12890-016-0250-0.

17.

Handheld single photon emission computed tomography (handheld SPECT) navigated video-assisted thoracoscopic surgery of computer tomography-guided radioactively marked pulmonary lesions.

Müller J, Putora PM, Schneider T, Zeisel C, Brutsche M, Baty F, Markus A, Kick J.

Interact Cardiovasc Thorac Surg. 2016 Sep;23(3):345-50. doi: 10.1093/icvts/ivw136. Epub 2016 May 20.

PMID:
27207315
18.

61PD 24h-blood profile gene expression biomarkers of the response to targeted therapy in advanced non-squamous non-small cell lung cancer (NSCLC).

Baty F, Jörger M, Frueh M, Brutsche MH.

J Thorac Oncol. 2016 Apr;11(4 Suppl):S81. doi: 10.1016/S1556-0864(16)30174-5. Epub 2016 Apr 15. No abstract available.

19.

169P: Chemotherapy is not superior to erlotinib in pretreated patients with advanced non-small cell lung cancer (NSCLC): A retrospective study.

Neumair P, Joos L, Warschkow R, Ess S, Hitz F, Frueh M, Brutsche MH, Baty F, Krähenbühl S, Jörger M.

J Thorac Oncol. 2016 Apr;11(4 Suppl):S131. doi: 10.1016/S1556-0864(16)30279-9. Epub 2016 Apr 15. No abstract available.

20.

In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012.

Pohle S, Baty F, Brutsche M.

PLoS One. 2016 Mar 17;11(3):e0151940. doi: 10.1371/journal.pone.0151940. eCollection 2016.

21.

Stair dimension affects knee kinematics and kinetics in patients with good outcome after TKA similarly as in healthy subjects.

Trinler UK, Baty F, Mündermann A, Fenner V, Behrend H, Jost B, Wegener R.

J Orthop Res. 2016 Oct;34(10):1753-1761. doi: 10.1002/jor.23181. Epub 2016 Jun 2.

22.

Dose-Response Analysis Using R.

Ritz C, Baty F, Streibig JC, Gerhard D.

PLoS One. 2015 Dec 30;10(12):e0146021. doi: 10.1371/journal.pone.0146021. eCollection 2015.

23.

High-throughput alternative splicing detection using dually constrained correspondence analysis (DCCA).

Baty F, Klingbiel D, Zappa F, Brutsche M.

J Biomed Inform. 2015 Dec;58:175-185. doi: 10.1016/j.jbi.2015.10.002. Epub 2015 Oct 19.

24.

Effect of telemetric monitoring in the first 30 days of continuous positive airway pressure adaptation for obstructive sleep apnoea syndrome - a controlled pilot study.

Frasnelli M, Baty F, Niedermann J, Brutsche MH, Schoch OD.

J Telemed Telecare. 2016 Jun;22(4):209-14. doi: 10.1177/1357633X15598053. Epub 2015 Aug 6.

PMID:
26253747
25.

Small RNA profiling reveals deregulated phosphatase and tensin homolog (PTEN)/phosphoinositide 3-kinase (PI3K)/Akt pathway in bronchial smooth muscle cells from asthmatic patients.

Alexandrova E, Miglino N, Hashim A, Nassa G, Stellato C, Tamm M, Baty F, Brutsche M, Weisz A, Borger P.

J Allergy Clin Immunol. 2016 Jan;137(1):58-67. doi: 10.1016/j.jaci.2015.05.031. Epub 2015 Jul 3.

PMID:
26148798
26.

Gene Expression Signatures Predictive of Bevacizumab/Erlotinib Therapeutic Benefit in Advanced Nonsquamous Non-Small Cell Lung Cancer Patients (SAKK 19/05 trial).

Franzini A, Baty F, Macovei II, Dürr O, Droege C, Betticher D, Grigoriu BD, Klingbiel D, Zappa F, Brutsche MH.

Clin Cancer Res. 2015 Dec 1;21(23):5253-63. doi: 10.1158/1078-0432.CCR-14-3135. Epub 2015 Apr 28.

27.

Pharmacokinetically based dosing of weekly paclitaxel to reduce drug-related neurotoxicity based on a single sample strategy.

Kraff S, Nieuweboer AJ, Mathijssen RH, Baty F, de Graan AJ, van Schaik RH, Jaehde U, Joerger M.

Cancer Chemother Pharmacol. 2015 May;75(5):975-83. doi: 10.1007/s00280-015-2724-9. Epub 2015 Mar 12.

PMID:
25761456
28.

Improving wellbeing and self-efficacy by social prescription.

Morton L, Ferguson M, Baty F.

Public Health. 2015 Mar;129(3):286-9. doi: 10.1016/j.puhe.2014.12.011. Epub 2015 Mar 2. No abstract available.

PMID:
25744110
29.

Oxygen kinetics during 6-minute walk tests in patients with cardiovascular and pulmonary disease.

Kern L, Condrau S, Baty F, Wiegand J, van Gestel AJ, Azzola A, Tamm M, Brutsche M.

BMC Pulm Med. 2014 Oct 29;14:167. doi: 10.1186/1471-2466-14-167.

30.

Cardiopulmonary and gas-exchange responses during the six-minute walk test in patients with chronic obstructive pulmonary disease.

van Gestel AJ, Baty F, Rausch-Osthof AK, Brutsche MH.

Respiration. 2014;88(4):307-14. doi: 10.1159/000365997. Epub 2014 Sep 9.

31.

The outcome of community-acquired pneumonia in patients with chronic lung disease: a case-control study.

Dusemund F, Chronis J, Baty F, Albrich WC, Brutsche MH.

Swiss Med Wkly. 2014 Sep 3;144:w14013. doi: 10.4414/smw.2014.14013. eCollection 2014.

32.

Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).

Joerger M, Baty F, Früh M, Droege C, Stahel RA, Betticher DC, von Moos R, Ochsenbein A, Pless M, Gautschi O, Rothschild S, Brauchli P, Klingbiel D, Zappa F, Brutsche M.

Lung Cancer. 2014 Aug;85(2):306-13. doi: 10.1016/j.lungcan.2014.04.014. Epub 2014 May 29.

PMID:
24928469
33.

Significant reduction of AECOPD hospitalisations after implementation of a public smoking ban in Graubünden, Switzerland.

Dusemund F, Baty F, Brutsche MH.

Tob Control. 2015 Jul;24(4):404-7. doi: 10.1136/tobaccocontrol-2013-051290. Epub 2014 Feb 5.

PMID:
24500271
34.

Ocular injuries with a metallic foreign body in the posterior segment as a result of hammering: the visual outcome and prognostic factors.

Valmaggia C, Baty F, Lang C, Helbig H.

Retina. 2014 Jun;34(6):1116-22. doi: 10.1097/IAE.0000000000000062.

PMID:
24368309
35.

Baseline predictors of adherence to positive airway pressure therapy for sleep apnea: a 10-year single-center observational cohort study.

Schoch OD, Baty F, Niedermann J, Rüdiger JJ, Brutsche MH.

Respiration. 2014;87(2):121-8. doi: 10.1159/000354186. Epub 2013 Nov 5.

36.

VEGFA variants are associated with pre-school lung function, but not neonatal lung function.

Kreiner-Møller E, Chawes BL, Vissing NH, Koppelman GH, Postma DS, Madsen JS, Olsen DA, Baty F, Vonk JM, Kerkhof M, Sleiman P, Hakonarsson H, Mortensen LJ, Poorisrisak P, Bisgaard H, Bønnelykke K.

Clin Exp Allergy. 2013 Nov;43(11):1236-45. doi: 10.1111/cea.12188.

PMID:
24152156
37.

Retrieval of additional epinephrine from auto-injectors.

Hawkins SC, Weil C, Baty F, Fitzpatrick D, Rowell B.

Wilderness Environ Med. 2013 Dec;24(4):434-44. doi: 10.1016/j.wem.2013.03.025. Epub 2013 Sep 14.

PMID:
24041621
38.

EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancer.

Baty F, Rothschild S, Früh M, Betticher D, Dröge C, Cathomas R, Rauch D, Gautschi O, Bubendorf L, Crowe S, Zappa F, Pless M, Brutsche M; Swiss Group for Clinical Cancer Research.

PLoS One. 2013 Sep 10;8(9):e72966. doi: 10.1371/journal.pone.0072966. eCollection 2013.

39.

Exploring the transcription factor activity in high-throughput gene expression data using RLQ analysis.

Baty F, Rüdiger J, Miglino N, Kern L, Borger P, Brutsche M.

BMC Bioinformatics. 2013 Jun 6;14:178. doi: 10.1186/1471-2105-14-178.

40.

Comorbidities and burden of COPD: a population based case-control study.

Baty F, Putora PM, Isenring B, Blum T, Brutsche M.

PLoS One. 2013 May 17;8(5):e63285. doi: 10.1371/journal.pone.0063285. Print 2013.

41.

VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528.

Gautschi O, Dingemans AM, Crowe S, Peters S, Roder H, Grigorieva J, Roder J, Zappa F, Pless M, Brutsche M, Baty F, Bubendorf L, Hsu Schmitz SF, Na KJ, Carbone D, Stahel R, Smit E.

Lung Cancer. 2013 Jan;79(1):59-64. doi: 10.1016/j.lungcan.2012.10.006. Epub 2012 Nov 1.

PMID:
23122759
42.

Asthma and the regulated retrotransposon transcriptome.

Miglino N, Roth M, Baty F, Brutsche M, Tamm M, Borger P.

Eur Respir J. 2012 Sep;40(3):788-90. doi: 10.1183/09031936.00189811. No abstract available.

43.

Infraclavicular sensor site: a new promising site for transcutaneous capnography.

Chhajed PN, Chaudhari P, Tulasigeri C, Kate A, Kesarwani R, Miedinger D, Leuppi J, Baty F.

Scand J Clin Lab Invest. 2012 Jul;72(4):340-2. doi: 10.3109/00365513.2012.671490. Epub 2012 Mar 24.

PMID:
22443124
44.

Global gene expression analysis of the interaction between cancer cells and osteoblasts to predict bone metastasis in breast cancer.

Rajski M, Vogel B, Baty F, Rochlitz C, Buess M.

PLoS One. 2012;7(1):e29743. doi: 10.1371/journal.pone.0029743. Epub 2012 Jan 3.

45.

Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study.

Bisgaard H, Hermansen MN, Bønnelykke K, Stokholm J, Baty F, Skytt NL, Aniscenko J, Kebadze T, Johnston SL.

BMJ. 2010 Oct 4;341:c4978. doi: 10.1136/bmj.c4978.

46.

Six-minute walk test enhanced by mobile telemetric cardiopulmonary monitoring.

Tueller C, Kern L, Azzola A, Baty F, Condrau S, Wiegand J, Tamm M, Brutsche M.

Respiration. 2010;80(5):410-8. doi: 10.1159/000319834. Epub 2010 Aug 10.

47.

Therapeutic bronchoscopy for malignant airway stenoses: choice of modality and survival.

Chhajed PN, Somandin S, Baty F, Mehta AJ, Azzola A, Leuppi J, Tamm M, Brutsche MH.

J Cancer Res Ther. 2010 Apr-Jun;6(2):204-9. doi: 10.4103/0973-1482.65250.

48.

Combined airway and oesophageal stenting in malignant airway-oesophageal fistulas: a prospective study.

Herth FJ, Peter S, Baty F, Eberhardt R, Leuppi JD, Chhajed PN.

Eur Respir J. 2010 Dec;36(6):1370-4. doi: 10.1183/09031936.00049809. Epub 2010 Jun 4.

49.

Physical activity in young children is reduced with increasing bronchial responsiveness.

Brasholt M, Baty F, Bisgaard H.

J Allergy Clin Immunol. 2010 May;125(5):1007-12. doi: 10.1016/j.jaci.2010.02.002. Epub 2010 Apr 14.

PMID:
20392480
50.

Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia.

Liu T, Jankovic D, Brault L, Ehret S, Baty F, Stavropoulou V, Rossi V, Biondi A, Schwaller J.

Leukemia. 2010 Mar;24(3):601-12. doi: 10.1038/leu.2009.272. Epub 2010 Jan 14.

PMID:
20072157

Supplemental Content

Support Center